# A Phase I Study of SNH-119014 in Healthy Volunteers

> **NCT07087262** · PHASE1 · RECRUITING · sponsor: **ScinnoHub Pharmaceutical Co., Ltd.** · enrollment: 96 (estimated)

## Conditions studied

- Hemoglobinopathy

## Interventions

- **DRUG:** SNH-119014
- **DRUG:** Placebo

## Key facts

- **NCT ID:** NCT07087262
- **Lead sponsor:** ScinnoHub Pharmaceutical Co., Ltd.
- **Sponsor class:** INDUSTRY
- **Phase:** PHASE1
- **Study type:** INTERVENTIONAL
- **Status:** RECRUITING
- **Start date:** 2025-06-27
- **Primary completion:** 2026-03-28
- **Final completion:** 2026-03-28
- **Target enrollment:** 96 (ESTIMATED)
- **Last updated:** 2025-07-25


## Primary source

ClinicalTrials.gov registry: https://clinicaltrials.gov/study/NCT07087262

## Citation

> US National Library of Medicine, ClinicalTrials.gov registration NCT07087262, "A Phase I Study of SNH-119014 in Healthy Volunteers". Retrieved via AI Analytics 2026-05-24 from https://api.ai-analytics.org/clinical/NCT07087262. Licensed CC0.

---

*[Clinical trials dataset](/datasets/clinical-trials) · CC0 1.0*